$312 Million is the total value of Defender Capital, LLC.'s 43 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 14.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
VGSH | Sell | VANGUARD SHORT TERM TREASURYetf | $43,414,000 | -1.1% | 713,696 | -0.1% | 13.92% | -2.5% |
COST | Sell | COSTCO WHOLESALE CO | $20,221,000 | +16.2% | 35,618 | -7.8% | 6.48% | +14.5% |
CFX | Sell | COLFAX CORPORATION | $9,899,000 | -6.5% | 215,341 | -5.4% | 3.17% | -7.8% |
PLTR | Sell | PALANTIR TECHNOLOGIEScl a | $2,227,000 | -25.8% | 122,310 | -1.8% | 0.71% | -26.8% |
CGEN | Sell | COMPUGEN LIMITED Ford | $910,000 | -38.0% | 211,522 | -13.6% | 0.29% | -38.8% |
MSFT | Sell | MICROSOFT CORP | $695,000 | +6.3% | 2,065 | -11.0% | 0.22% | +4.7% |
INO | Sell | INOVIO PHARMA | $514,000 | -42.1% | 103,038 | -17.9% | 0.16% | -42.7% |
NUAN | Sell | NUANCE COMMUN INC | $318,000 | -84.3% | 5,750 | -84.4% | 0.10% | -84.5% |
VSAT | Sell | VIASAT INC | $267,000 | -70.0% | 6,000 | -62.5% | 0.09% | -70.3% |
CSCO | Sell | CISCO SYSTEMS INC | $254,000 | +10.0% | 4,016 | -5.3% | 0.08% | +8.0% |
RUN | Sell | SUNRUN | $240,000 | -42.3% | 7,000 | -12.5% | 0.08% | -43.0% |
AGE | Sell | AGEX THERAPEUTICS INC | $38,000 | +15.2% | 34,767 | -0.4% | 0.01% | +9.1% |
ARWR | Exit | ARROWHEAD PHARMACUTICALS | $0 | – | -6,000 | -100.0% | -0.13% | – |
PSJ | Exit | INVESCO DYNAMIC SOFTWAREetf | $0 | – | -11,095 | -100.0% | -0.52% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-01
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BERKSHIRE HATHAWAY INC DEL CL B | 20 | Q3 2023 | 24.4% |
DANAHER CORPORATION COM | 20 | Q3 2023 | 18.3% |
STAAR SURGICAL CORPORATION | 20 | Q3 2023 | 20.2% |
FORTIVE CORPORATION | 20 | Q3 2023 | 14.3% |
MONSTER BEVERAGE CORPORATION | 20 | Q3 2023 | 17.3% |
APPLE INC | 20 | Q3 2023 | 0.6% |
AMAZON INC COM | 20 | Q3 2023 | 0.4% |
VANGUARD SHORT TERM TREASURY ETF IV | 17 | Q3 2023 | 23.9% |
LINEAGE CELL THERAPEUTICS INC | 17 | Q3 2023 | 4.8% |
COMPUGEN LTD ORD | 17 | Q1 2023 | 1.9% |
View Defender Capital, LLC.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-06 |
13F-HR | 2024-01-23 |
13F-HR | 2023-10-23 |
13F-HR | 2023-07-18 |
13F-HR/A | 2023-05-16 |
13F-HR | 2023-04-27 |
13F-HR | 2023-01-12 |
13F-HR | 2022-10-18 |
13F-HR | 2022-07-26 |
13F-HR/A | 2022-06-07 |
View Defender Capital, LLC.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.